Genetics and Geoepidemiology of Primary Biliary Cirrhosis: Following the Footprints to Disease Etiology

ABSTRACT

The etiopathogenesis of primary biliary cirrhosis (PBC), an autoimmune disease characterized by the progressive destruction of intrahepatic bile ducts, is still enigmatic. There is growing evidence that suggests that the disease results from a combination of genetic and environmental factors. PBC should be regarded as a peculiar, yet representative autoimmune disease. For example, the relative risk for siblings and the concordance rate in monozygotic twins in PBC are among the highest reported in autoimmune conditions. Association studies for specific genes have provided weak associations, which often are limited to specific geographical areas. Interestingly, PBC epidemiology also presents a geographical pattern; it is more common in the northern parts of Europe and United States. In this article, we critically review available evidence regarding genetics and geoepidemiology in PBC. We also submit possible interpretations of data, new developments and theories, and attempt to indicate directions for future research efforts.

KEYWORDS

Autoimmune cholangitis - antimitochondrial antibodies - multigene - geographical pattern

REFERENCES

• 1 Talwalkar J A, Lindor K D. Primary biliary cirrhosis.  Lancet. 2003;  362 53-61
• 2 Prince M, Chetwynd A, Newman W et al.. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years.  Gastroenterology. 2002;  123 1044-1051
• 3 Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis.  Cochrane Database Syst Rev. 2002;  CD000551
• 4 MacQuillan G C, Neuberger J. Liver transplantation for primary biliary cirrhosis.  Clin Liver Dis. 2003;  7 941-956 ix
• 5 Risch N. Searching for genes in complex diseases: lessons from systemic lupus erythematosus.  J Clin Invest. 2000;  105 1503-1506
• 6 Cardon L R, Bell J I. Association study designs for complex diseases.  Nat Rev Genet. 2001;  2 91-99
• 7 Becker K G, Simon R M, Bailey-Wilson J E et al.. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.  Proc Natl Acad Sci USA. 1998;  95 9979-9984
• 8 Hirschhorn J N, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies.  Genet Med. 2002;  4 45-61
• 9 Perneger T V. What's wrong with Bonferroni adjustments.  BMJ. 1998;  316 1236-1238
• 10 Ichiki Y, Shimoda S, Ishibashi H, Gershwin M E. Is primary biliary cirrhosis a model autoimmune disease?.  Autoimmun Rev. 2004;  3 331-336
• 11 Donaldson P, Agarwal K, Craggs A et al.. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility.  Gut. 2001;  48 397-402
• 12 Selmi C, Mayo M J, Bach N et al.. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment.  Gastroenterology. 2004;  127 485-492
• 13 Greco L, Romino R, Coto I et al.. The first large population based twin study of coeliac disease.  Gut. 2002;  50 624-628
• 14 Selmi C, Invernizzi P, Miozzo M et al.. Primary biliary cirrhosis: does X mark the spot?.  Autoimmun Rev. 2004;  3 493-499
• 15 Whitacre C C. Sex differences in autoimmune disease.  Nat Immunol. 2001;  2 777-780
• 16 Invernizzi P, Miozzo M, Battezzati P M et al.. Frequency of monosomy X in women with primary biliary cirrhosis.  Lancet. 2004;  363 533-535
• 17 Brind A M, Bray G P, Portmann B C, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis.  Gut. 1995;  36 615-617
• 18 Hamlyn A N, Macklon A F, James O. Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality.  Gut. 1983;  24 940-945
• 19 Myszor M, James O F. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?.  Q J Med. 1990;  75 377-385
• 20 James O F, Bhopal R, Howel D et al.. Primary biliary cirrhosis once rare, now common in the United Kingdom?.  Hepatology. 1999;  30 390-394
• 21 Bach N, Schaffner F. Familial primary biliary cirrhosis.  J Hepatol. 1994;  20 698-701
• 22 Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden.  Hepatology. 1990;  11 458-464
• 23 Floreani A, Naccarato R, Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy.  J Hepatol. 1997;  26 737-738
• 24 Tsuji K, Watanabe Y, Van De Water J et al.. Familial primary biliary cirrhosis in Hiroshima.  J Autoimmun. 1999;  13 171-178
• 25 Kim W R, Lindor K D, Locke III G R et al.. Epidemiology and natural history of primary biliary cirrhosis in a US community.  Gastroenterology. 2000;  119 1631-1636
• 26 Jones D E, Watt F E, Metcalf J V et al.. Familial primary biliary cirrhosis reassessed: a geographically-based population study.  J Hepatol. 1999;  30 402-407
• 27 Olafsson S, Gudjonsson H, Selmi C et al.. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives.  Am J Gastroenterol. 2004;  99 2143-2146
• 28 Feizi T, Naccarato R, Sherlock S, Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis.  Clin Exp Immunol. 1972;  10 609-622
• 29 Galbraith R M, Smith M, Mackenzie R M et al.. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.  N Engl J Med. 1974;  290 63-69
• 30 Watt F E, James O F, Jones D E. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study.  QJM. 2004;  97 397-406
• 31 Bittencourt P L, Farias A Q, Abrantes-Lemos C P et al.. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.  J Gastroenterol Hepatol. 2004;  19 873-878
• 32 MacGregor A J, Snieder H, Rigby A S et al.. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.  Arthritis Rheum. 2000;  43 30-37
• 33 Chohan M R. Primary biliary cirrhosis in twin sisters.  Gut. 1973;  14 213-214
• 34 Kaplan M M, Rabson A R, Lee Y M et al.. Discordant occurrence of primary biliary cirrhosis in monozygotic twins.  N Engl J Med. 1994;  331 951
• 35 Freeman H J. Primary biliary cirrhosis in genetically identical twins.  Gastroenterology. 2004;  127 1645
• 36 Selmi C, Gershwin M E. Reply to Dr. Freeman.  Gastroenterology. 2004;  127 1645
• 37 Selmi C, Gershwin M E. Bacteria and human autoimmunity: the case of primary biliary cirrhosis.  Curr Opin Rheumatol. 2004;  16 406-410
• 38 Kita H, He X S, Gershwin M E. Autoimmunity and environmental factors in the pathogenesis of primary biliary cirrhosis.  Ann Med. 2004;  36 72-80
• 39 McCluskey J, Peh C A. The human leucocyte antigens and clinical medicine: an overview.  Rev Immunogenet. 1999;  1 3-20
• 40 Carson D A. Genetic factors in the etiology and pathogenesis of autoimmunity.  FASEB J. 1992;  6 2800-2805
• 41 Ercilla G, Parés A, Arriaga F et al.. Primary biliary cirrhosis associated with DLA-DRw3.  Tissue Antigens. 1979;  14 449-452
• 42 Miyamori H, Kato Y, Kobayashi K, Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis.  Digestion. 1983;  26 213-217
• 43 Onishi S, Sakamaki T, Maeda T et al.. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis.  J Hepatol. 1994;  21 1053-1060
• 44 Bassendine M F, Dewar P J, James O F. HLA-DR antigens in primary biliary cirrhosis: lack of association.  Gut. 1985;  26 625-628
• 45 Briggs D C, Donaldson P T, Hayes P et al.. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC).  Tissue Antigens. 1987;  29 141-145
• 46 Manns M P, Bremm A, Schneider P M et al.. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis.  Gastroenterology. 1991;  101 1367-1373
• 47 Morling N, Dalhoff K, Fugger L et al.. DNA polymorphism of HLA class II genes in primary biliary cirrhosis.  Immunogenetics. 1992;  35 112-116
• 48 Invernizzi P, Battezzati P M, Crosignani A et al.. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis.  J Hepatol. 2003;  38 401-406
• 49 Gores G J, Moore S B, Fisher L D et al.. Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens.  Hepatology. 1987;  7 889-892
• 50 Begovich A B, Klitz W, Moonsamy P V et al.. Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis.  Tissue Antigens. 1994;  43 71-77
• 51 Wassmuth R, Depner F, Danielsson A et al.. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis.  Tissue Antigens. 2002;  59 381-387
• 52 Zhang L, Weetman A P, Bassendine M, Oliveira D B. Major histocompatibility complex class-II alleles in primary biliary cirrhosis.  Scand J Immunol. 1994;  39 104-106
• 53 Bittencourt P L, Palacios S A, Farias A Q et al.. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis.  J Gastroenterol Hepatol. 2003;  18 1061-1066
• 54 Mella J G, Roschmann E, Maier K P, Volk B A. Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population.  Hepatology. 1995;  21 398-402
• 55 Seki T, Kiyosawa K, Ota M et al.. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients.  Hepatology. 1993;  18 73-78
• 56 Gregory W L, Daly A K, Dunn A N et al.. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis.  Q J Med. 1994;  87 237-244
• 57 Donaldson P T. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal.  J Hepatol. 1999;  31 366-368
• 58 Wilson A G, di Giovine F S, Blakemore A I, Duff G W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.  Hum Mol Genet. 1992;  1 353
• 59 Wilson A G, Symons J A, McDowell T L et al.. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.  Proc Natl Acad Sci USA. 1997;  94 3195-3199
• 60 Kroeger K M, Carville K S, Abraham L J. The - 308 tumor necrosis factor-alpha promoter polymorphism effects transcription.  Mol Immunol. 1997;  34 391-399
• 61 Wu W S, McClain K L. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH).  J Interferon Cytokine Res. 1997;  17 631-635
• 62 Gordon M A, Oppenheim E, Camp N J et al.. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region [see comments].  J Hepatol. 1999;  31 242-247
• 63 Tanaka A, Quaranta S, Mattalia A et al.. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis.  J Hepatol. 1999;  30 826-829
• 64 Jones D E, Watt F E, Grove J et al.. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis [see comments].  J Hepatol. 1999;  30 232-236
• 65 Dickson E R, Grambsch P M, Fleming T R et al.. Prognosis in primary biliary cirrhosis: model for decision making.  Hepatology. 1989;  10 1-7
• 66 Bathgate A J, Pravica V, Perrey C et al.. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease.  Eur J Gastroenterol Hepatol. 2000;  12 1329-1333
• 67 Fan L Y, Zhong R Q, Tu X Q et al.. Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population.  Zhonghua Gan Zang Bing Za Zhi. 2004;  12 160-162
• 68 Jazrawi S F, Zaman A, Muhammad Z et al.. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.  Liver Transpl. 2003;  9 377-382
• 69 Sachidanandam R, Weissman D, Schmidt S C et al.. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms.  Nature. 2001;  409 928-933
• 70 Agarwal K, Jones D E, Daly A K et al.. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. [in process citation].  J Hepatol. 2000;  32 538-541
• 71 Fan L Y, Tu X Q, Cheng Q B et al.. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.  World J Gastroenterol. 2004;  10 3056-3059
• 72 Kershenobich D, Rojkind M, Quiroga A, Alcocer-Varela J. Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis.  Hepatology. 1990;  11 205-209
• 73 Lakatos L P, Bajnok E, Hegedus D et al.. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis.  Eur J Gastroenterol Hepatol. 2002;  14 733-740
• 74 Fan L Y, Zhu Y, Zhong R Q et al.. Genetic association between interleukins gene polymorphisms with primary biliary cirrhosis in Chinese population.  Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;  26 505-509
• 75 Matsushita M, Tanaka A, Kikuchi K et al.. Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients.  Autoimmunity. 2002;  35 531-536
• 76 Vogel A, Strassburg C P, Manns M P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.  Hepatology. 2002;  35 126-131
• 77 Halmos B, Szalay F, Cserniczky T et al.. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population.  Dig Dis Sci. 2000;  45 1091-1095
• 78 Fan L Y, Zhong R Q, Tu X Q et al.. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese.  Zhonghua Yi Xue Za Zhi. 2003;  83 1852-1855
• 79 Springer J E, Cole D E, Rubin L A et al.. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis.  Gastroenterology. 2000;  118 145-151
• 80 Pares A, Guanabens N, Alvarez L et al.. Collagen type I alpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.  Hepatology. 2001;  33 554-560
• 81 Vong S, Bell B P. Chronic liver disease mortality in the United States, 1990-1998.  Hepatology. 2004;  39 476-483
• 82 Long S A, Quan C, Van de Water J et al.. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis.  J Immunol. 2001;  167 2956-2963
• 83 Kimura Y, Selmi C, Leung P S et al.. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis.  Hepatology. 2005;  41 55-63
• 84 Pauli-Magnus C, Kerb R, Fattinger K et al.. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.  Hepatology. 2004;  39 779-791
• 85 Pauli-Magnus C, Lang T, Meier Y et al.. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.  Pharmacogenetics. 2004;  14 91-102
• 86 Ku N O, Darling J M, Krams S M et al.. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.  Proc Natl Acad Sci USA. 2003;  100 6063-6068
• 87 Higuchi M, Horiuchi T, Kojima T et al.. Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis.  Scand J Clin Lab Invest. 1998;  58 429-432
• 88 Corpechot C, Poupon R. Promoter polymorphism of the CD14 endotoxin receptor gene and primary biliary cirrhosis.  Hepatology. 2002;  35 242-243
• 89 Selmi C, Zuin M, Biondi M L et al.. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity.  J Gastroenterol Hepatol. 2003;  18 1150-1155
• 90 Kikuchi K, Tanaka A, Miyakawa H et al.. Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis.  Hepatol Res. 2003;  26 87-90
• 91 Selmi C, Invernizzi P, Tripputi P et al.. T-cell receptor polymorphism in primary biliary cirrhosis.  Ann Ital Med Int. 2003;  18 149-153
• 92 Lakatos P L, Bajnok E, Tornai I et al.. Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis.  Eur J Gastroenterol Hepatol. 2004;  16 753-759
• 93 Ranke M B, Saenger P. Turner's syndrome.  Lancet. 2001;  358 309-314
• 94 Davis C J, Davison R M, Payne N N et al.. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion.  Hum Reprod. 2000;  15 2418-2422
• 95 Kaplan M M, Bianchi D W. Primary biliary cirrhosis: for want of an X chromosome?.  Lancet. 2004;  363 505-506
• 96 Guttenbach M, Koschorz B, Bernthaler U et al.. Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei.  Am J Hum Genet. 1995;  57 1143-1150
• 97 Lambert N, Nelson J L. Microchimerism in autoimmune disease: more questions than answers?.  Autoimmun Rev. 2003;  2 133-139
• 98 Fanning P A, Jonsson J R, Clouston A D et al.. Detection of male DNA in the liver of female patients with primary biliary cirrhosis.  J Hepatol. 2000;  33 690-695
• 99 Tanaka A, Lindor K, Gish R et al.. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis.  Hepatology. 1999;  30 833-838
• 100 Invernizzi P, De Andreis C, Sirchia S M et al.. Blood fetal microchimerism in primary biliary cirrhosis.  Clin Exp Immunol. 2000;  122 418-422
• 101 Oertelt S, Selmi C, Invernizzi P et al.. Genes and goals: an approach to microarray analysis in autoimmunity.  Autoimmun Rev. , In press
• 102 Hinds D A, Stuve L L, Nilsen G B et al.. Whole-genome patterns of common DNA variation in three human populations.  Science. 2005;  307 1072-1079
• 103 Abu-Mouch S, Selmi C, Benson G D et al.. Geographic clusters of primary biliary cirrhosis.  Clin Dev Immunol. 2003;  10 127-131
• 104 Arbour L, Field L, Ross P et al.. The mystery of primary biliary cirrhosis in British Columbia's First Nations people.  Int J Circumpolar Health. 2004;  63(suppl 2) 185-188
• 105 Ala A, Ahmado I, Stanca C et al.. The prevalence of primary biliary cirrhosis is increased near toxic waste sites in New York City.  Hepatology. 2004;  40 205A
• 106 Metcalf J V, Bhopal R S, Gray J et al.. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England.  Int J Epidemiol. 1997;  26 830-836
• 107 Triger D R. Primary biliary cirrhosis: an epidemiological study.  BMJ. 1980;  281 772-775
• 108 Kaplan M M. Primary biliary cirrhosis.  N Engl J Med. 1996;  335 1570-1580
• 109 Hislop W S, Main G, Robertson A J. Primary biliary cirrhosis: experience in a non-referral centre.  Lancet. 1981;  2 144
• 110 Goudie B, MacFarlane G, Boyle P. Epidemiology of antimitichondrial antibody seropositivity and primary biliary cirrhosis in west of Scotland.  Gut. 1987;  28 A1346
• 111 Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population.  Scand J Gastroenterol. 1984;  19 971-976
• 112 Lofgren J, Jarnerot G, Danielsson D, Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden.  Scand J Gastroenterol. 1985;  20 647-650
• 113 Remmel T, Remmel H, Uibo R, Salupere V. Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome.  Scand J Gastroenterol. 1995;  30 367-371
• 114 Triger D R, Berg P A, Rodes J. Epidemiology of primary biliary cirrhosis.  Liver. 1984;  4 195-200
• 115 Shibata M, Onozuka Y, Morizane T et al.. Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture.  J Gastroenterol. 2004;  39 255-259
• 116 Watson R G, Angus P W, Dewar M et al.. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group.  Gut. 1995;  36 927-930
• 117 Sood S, Gow P J, Christie J M, Angus P W. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations.  Gastroenterology. 2004;  127 470-475
• 118 Witt-Sullivan H, Heathcote J, Cauch K et al.. The demography of primary biliary cirrhosis in Ontario, Canada.  Hepatology. 1990;  12 98-105
• 119 He X S, Ansari A A, Gershwin M E. Xenobiotic considerations for the development of autoimmune liver diseases: bad genes and bad luck.  Rev Environ Health. 2001;  16 191-202
• 120 Johnston D E, Kaplan M M, Miller K B et al.. Histocompatibility antigens in primary biliary cirrhosis.  Am J Gastroenterol. 1987;  82 1127-1129
• 121 Prochazka E J, Terasaki P I, Park M S et al.. Association of primary sclerosing cholangitis with HLA-DRw52a.  N Engl J Med. 1990;  322 1842-1844
• 122 Underhill J, Donaldson P, Bray G et al.. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype.  Hepatology. 1992;  16 1404-1408
• 123 Underhill J A, Donaldson P T, Doherty D G et al.. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.  Hepatology. 1995;  21 959-962
• 124 Graham A M, Dollinger M M, Howie S E, Harrison D J. Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis.  J Med Genet. 2000;  37 150-152
• 125 Zappala F, Grove J, Watt F E et al.. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis.  J Hepatol. 1998;  28 820-823